Biotech & Life Sciences Fractional CFO Services | SeatonHill

We give life sciences companies a competitive edge in navigating every stage of development.

Capital Growth
Sale/IPO Readiness
Commercialization
Joint Ventures
Financial Reporting

Cash Flow Analysis & Management
Licensing Structuring, Negotiating, & Management
Industry-specific Strategic Guidance
Lender/Vendor/Stakeholder/Board Relations
ERP & Data Strategy

We understand the process and the difficulties brought on by clinical trials, research-centric models, capital requirements, and market developments.

Capital Management

With deep knowledge of transaction structures, we provide strategies for valuation models, the creation of investor decks, and the generation of term sheets. After securing funding, our CFOs also support contract compliance, cash management, investor reporting, strategic planning, and management decision-making, contributing critical analysis necessary to properly assess specific capital investments, purchases, and leasing arrangements.

Sale/IPO Readiness

With buy and sell side acquisition experience of various sizes, Our CFO Partners support the structuring, negotiations, and financial reporting of any proposed transaction through both qualitative and quantitative input, providing both strategic counseling and valuation modeling. We also guide companies through the complexities of the Sale/IPO process and preparation strategies designed to enhance value.

Partnerships, Licensing, & Joint Ventures

Identifying critical partnership, joint venture, and licensing relationships with effective structuring and negotiating of all underlying contracts and agreements is vital. We understand the importance of building these essential relationships and have extensive experience structuring positive, sustainable, and beneficial partnerships with a strategic approach to creating viability.

Commercialization

Introducing a new product to the market is a complex journey that requires addressing critical financial considerations within a competitive industry landscape. Our CFO’s have experience with bringing products to market and maintaining compliance across the product life cycle, including: • Assessing financial systems capabilities to support commercial processes with inventory management and sales/order management • Operationalizing Gross to Net (GTN) processes • State Licensing filing process • 3PL and wholesaler arrangements • Sales team assessment/analysis for inhouse vs. outsourcing and compensation plans

Cash Flow Management

Cash is the lifeblood of every business enterprise, and effectively forecasting, budgeting, and managing your company’s liquidity is key to achieving business objectives. With deep treasury experience in both large and small companies, our seasoned CFOs know how to successfully manage cash to optimize resource allocation decisions, maximize ROI, and mitigate financial risk.

Financial Reporting

Keeping your financials current and US GAAP compliant is the foundation upon which well-run companies are built. We have vast expertise in building accounting teams, enhancing GAAP financial statement capabilities, streamlining the reporting process, managing investor relations, and developing internal financial dashboards that support management and financial planning and analysis.

Bob Arnold
Partner

Meet the Partner

Bob has 14+ years of life sciences/pharmaceutical experience with Aquestive Therapeutics Inc. (AQST), where he was a member of the senior leadership team that built and grew the company from a start-up to a fully integrated (product development, manufacturing, product sales, and marketing) Public Company. Bob has multiple FDA-approved commercial products (proprietary and Licensed). He has also secured growth capital for the 2018 IPO (Nasdaq listed), raised pre- IPO $75 million equity and convertible debt, and led, managed, and supported multiple debt financing transactions ranging from $12.5 million venture debt facility in 2008 to $100 million facility with multiple participants in 2019.

Jack McGovern
Area Managing Partner

Meet the Partner

Jack served as Fractional CFO for Clairmed (a PortCo of NaviMed Capital), a platform company, rolling up outsourced Med Device development and clinical trials (e.g. Human Factors testing). He integrated 2 acquisitions, developed consolidated financial and cash management reporting, established new bank relations in response to SVB failure, selected the audit firm and implemented the initial audit, and transitioned to a full-time CFO after 8 months.

Jack Riccardi
Partner

Meet the Partner

With well over a decade of experience working in Life Sciences, Jack understands the enormity of the biotech mission to bring treatments to market that help people in great distress. Throughout his career, he has worked the full spectrum of finance and accounting functions, from auditing to financial reporting, and from treasury to strategic planning. Jack has assumed CFO leadership positions with numerous companies, both private and public, including Omni Bio (OMBP), Hemosonics, Adial Pharmaceuticals (ADIL), and Gateway Biotechnology. Having co-founded a start-up, he has experience building effective finance teams, securing both equity and debt funding, and preparing a company for IPO. Jack also has significant M&A experience, leading numerous transactions on both the sell and buy sides, ranging in size from $10 million to $250 million. He’s also been on both sides of the VC transaction as an investor and entrepreneur and knows how to negotiate strategic agreements.

Rhonda Rosen
Partner

Meet the Partner

Rhonda is a senior finance executive with an extensive skill set that spans all areas of finance, banking, and administration, including board and investor communications, M&A, public and private financing transactions, and initial public offerings. She has a proven track record leading the growth and dramatic improvement of multiple early-stage, mid-sized, and PE/VC-backed companies in the specialty pharmaceuticals, medical devices, and healthcare IT sectors.

Want to learn more?

Let’s start a conversation.